Prolonged anticoagulation in VTE with direct oral anticoagulants: towards an individual analysis of net clinical benefit? Source: Eur Respir J 2016; 48: 1268-1270 Year: 2016
Antibiotics as immunomodulators: a potential pharmacologic approach for ARDS treatment Source: Eur Respir Rev, 30 (162) 210093; 10.1183/16000617.0093-2021 Year: 2021
Current approaches to the prevention of tuberculosis in patients receiving immunosuppressants Source: Virtual Congress 2021 – Epidemiological aspects of tuberculosis Year: 2021
Antibiotics in critical care: dosing, therapeutic drug monitoring and continuous infusions Source: Eur Respir Monogr 2017; 75: 44-56 Year: 2017
Therapeutic strategies: what treatment for what patient Source: Annual Congress 2008 - PG12 - Challenges in pulmonary embolism: hot issues and interactive cases (jointly organised with ACCP) Year: 2008
Anticoagulant treatment of venous thromboembolism: established and new oral agents, remaining questions Source: International Congress 2014 – Current controversies in the management of acute pulmonary embolism Year: 2014
The issues and the controversies: are we really ready for on-demand use of ICS? Source: Annual Congress 2013 –Inhaled corticosteroids for asthma: on-demand or continuous use? Year: 2013
Therapeutic options for sarcoidosis: old and new Source: Annual Congress 2005 - PG15 - Therapeutic options for interstitial lung diseases in 2005 Year: 2005
Getting approval for new therapeutic medical devices versus drugs: are the differences justified? Source: Eur Respir Rev 2016; 25: 223-226 Year: 2016
HAP/VAP : new guidelines, new approaches Source: International Congress 2018 – Chinese Programme 2018: Part II Year: 2018
Prescription opioid use in advanced COPD: benefits, perils and controversies Source: Eur Respir J, 49 (6) 1700690; 10.1183/13993003.00690-2017 Year: 2017
Prescription opioid use in advanced COPD: benefits, perils and controversies Source: Eur Respir J, 49 (6) 1700479; 10.1183/13993003.00479-2017 Year: 2017
High-flow therapy: physiological effects and clinical applications Source: Breathe, 16 (4) 200224; 10.1183/20734735.0224-2020 Year: 2020
The efficacy and safety of adjunctive corticosteroids in the treatment of tuberculous pleurisyA systematic review and meta-analysis Source: International Congress 2017 – TB: diagnosis, severity and practical management Year: 2017
Consequences of long-term oral corticosteroid therapy and its side-effects in severe asthma in adults: a focused review of the impact data in the literature Source: Eur Respir J, 52 (4) 1800703; 10.1183/13993003.00703-2018 Year: 2018
Efficacy and safety of new drugs for M/XDR-TB: what have we learned from observational studies? Source: International Congress 2019 – Recent developments and future perspectives in the diagnosis and treatment of tuberculosis Year: 2019